NAPOLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 2.140
AS - Asia 825
EU - Europa 772
SA - Sud America 283
AF - Africa 34
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.057
Nazione #
US - Stati Uniti d'America 2.106
SG - Singapore 343
CN - Cina 245
BR - Brasile 242
SE - Svezia 221
IT - Italia 127
RU - Federazione Russa 117
HK - Hong Kong 102
DE - Germania 70
GB - Regno Unito 62
VN - Vietnam 55
UA - Ucraina 51
FI - Finlandia 41
FR - Francia 34
AR - Argentina 19
IN - India 17
MX - Messico 15
ZA - Sudafrica 15
BD - Bangladesh 14
BE - Belgio 13
CA - Canada 12
ID - Indonesia 11
CI - Costa d'Avorio 9
EC - Ecuador 9
ES - Italia 8
IQ - Iraq 7
NL - Olanda 7
PL - Polonia 7
PK - Pakistan 6
TR - Turchia 6
DZ - Algeria 4
IE - Irlanda 4
PY - Paraguay 4
SA - Arabia Saudita 4
AT - Austria 3
CO - Colombia 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
AL - Albania 2
IL - Israele 2
JP - Giappone 2
MA - Marocco 2
PA - Panama 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.057
Città #
Fairfield 253
Ashburn 225
Chandler 214
Singapore 177
Nyköping 161
Woodbridge 122
Seattle 107
Jacksonville 106
Houston 105
Hong Kong 101
Ann Arbor 99
Beijing 96
Cambridge 86
Wilmington 81
New York 55
Brooklyn 36
Lawrence 34
Roxbury 34
Los Angeles 33
Dallas 32
Nanjing 32
Des Moines 27
Boardman 20
Ostuni 20
Bari 19
Munich 19
São Paulo 19
Princeton 18
Santa Clara 18
Moscow 17
Nanchang 15
Helsinki 14
Brussels 13
Hanoi 13
Johannesburg 13
Ho Chi Minh City 12
Frankfurt am Main 10
Inglewood 10
Rio de Janeiro 10
Abidjan 9
Atlanta 9
Chicago 9
Dong Ket 9
Jakarta 9
Brasília 8
Buffalo 8
Hanover 8
London 8
Rome 8
Shenyang 8
Jiaxing 7
Columbus 6
Hebei 6
Poplar 6
San Diego 6
Tianjin 6
Baghdad 5
Belo Horizonte 5
Manchester 5
Porto Alegre 5
Querétaro 5
The Dalles 5
Warsaw 5
Zhengzhou 5
Campinas 4
Changsha 4
Dearborn 4
Denver 4
Dhaka 4
Dublin 4
Guangzhou 4
Montreal 4
Noci 4
Orem 4
Paris 4
Pune 4
San Francisco 4
Santo André 4
Taizhou 4
Taranto 4
Amman 3
Amsterdam 3
Ankara 3
Belford Roxo 3
Campo Grande 3
Chennai 3
Curitiba 3
Haiphong 3
Joinville 3
Kuala Lumpur 3
Kunming 3
Mexico City 3
Mogi das Cruzes 3
Mumbai 3
Ningbo 3
Padova 3
Redwood City 3
Riyadh 3
San Jose 3
Shanghai 3
Totale 2.770
Nome #
Hepatocellular Carcinoma: Known and Emerging Risk Factors 194
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 189
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 180
Kikuchi-Fujimoto Disease in an Old Italian Woman: Case Report and Review of the Literature 175
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 166
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 160
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 158
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 149
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 147
Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress. 146
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 143
Sierotipi del virus dell'epatite C e focalità tumorale in pazienti con cirrosi epatica HCV-correlata ed epatocarcinoma 141
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 140
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 135
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 132
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 131
Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy 125
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 111
Manifestazioni extraepatiche multiple in una paziente con epatite cronica C trattata con interferone-alfa 102
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alfa treatment for chronic hepatitis C: a new challenge for clinicians 98
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 97
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 96
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs 96
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 90
Prevalence of antibodies to hepatitis c virus among family members of patients with chronic hepatis c 89
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 89
Angiodisplasia gastrica di grave entità in un caso di porpore di Schonlein-Henoch 87
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 87
Vasculite sistemica secondaria a trattamento con alfa-interferone in un soggetto con crioglobulinemia mista di tipo II 83
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in Chronic Hepatitis C: a critical reappraisal 82
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C 78
Ribavirin and high dose of interferon-alfa for retreatment of patients with chronic hepatitis C resistant to IFN alone 66
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? 61
Relationship between HCV serotypes and tumor focality in HCV-infected cirrhotic patients with HCC 60
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response 55
Totale 4.138
Categoria #
all - tutte 16.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 15 42 22 29 87 33 22
2021/2022315 22 34 1 14 27 54 12 13 16 13 51 58
2022/2023568 79 80 52 52 68 75 3 61 81 5 7 5
2023/2024212 11 36 10 38 15 71 6 8 1 1 3 12
2024/2025786 21 13 61 36 28 68 145 71 28 40 104 171
2025/2026832 208 61 108 188 186 81 0 0 0 0 0 0
Totale 4.138